Buscar
Congreso SOLACI

Búsqueda de: aortic stenosis

Si no está conforme con los resultados, inténtelo de nuevamente.
Structural heart disease

ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes

At present, transcatheter aortic valve replacement (TAVR) has become the gold standard in the US, regardless surgical...
solaci -
Ir
Structural heart disease

Real-World Results of Different Devices for TAVR

Transcatheter aortic valve replacement (TAVR) keeps growing in terms of the development of new devices, more extensive...
solaci -
Ir
Chronic Ischemic cardiopathy

We Should Treat Significant Stable CAD in Patients Undergoing TAVR

Aortic stenosis is associated to significant coronary artery disease (CAD) in nearly 50% of cases.  When we decide...
solaci -
Ir
Structural heart disease

Is There any Difference between Modern Valves and Self and Balloon Expandable Valves?

At present TAVR is a valid alternative to treat different risk groups of patients with severe aortic...
solaci -
Ir
Structural heart disease

SURTAVI at 5 Years

Transcatheter aortic valve replacement (TAVR) by transfemoral access has shown great benefit for different risk groups, but...
solaci -
Ir
Valvular Aortic Valve

Is Right Ventricle-Pulmonary Artery (RV-PA) Coupling Important in Low Risk TAVR?

TAVR has long been an effective strategy to treat aortic stenosis. However, ventricular damage starts further before...
solaci -
Ir
Structural Heart Disease

TCT 2022 | PROTECTED TAVR

Stroke is still a major complication of transcatheter aortic valve replacement (TAVR), with a 30-day mortality of...
solaci -
Ir
Antithrombotic Anticoagulants

Apixaban and Valve Thrombosis after TAVR

TAVR has been associated with early valve thrombosis, characterized by thrombus formation in the prosthetic valve with...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

solaci - 0
Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging, as is low patient adherence, be it...

Myocardial Damage in MAC

solaci - 0
Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in women and patients with renal insufficiency. This...

Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease

solaci - 0
In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel disease is observed in up to 40%...

Noticias Institucionales

National and Internacional Live Cases at the Next SOLACI-CACI 2024

solaci - 0
Discover all the live national and international cases at the upcoming SOLACI-CACI 2024 Congress. Scientific program Register now con descuentos   Live International Transmission Tribute to Alain Cribier...

Discover the international guests of the SOLACI-CACI 2024 Congress

solaci - 0
We are getting closer to the largest gathering of interventional cardiologists in Latin America. Discover the prestigious guests from Europe, Asia, and the United...

New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

solaci - 0
We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad